<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03437252</url>
  </required_header>
  <id_info>
    <org_study_id>2017-11-009-002</org_study_id>
    <nct_id>NCT03437252</nct_id>
  </id_info>
  <brief_title>Physical Activity in Chronic Obstructive Pulmonary Disease(COPD) Acute Exacerbation Patients</brief_title>
  <official_title>The Association of Physical Activity With Readmission Due to Exacerbation in COPD Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Samsung Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Samsung Medical Center</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients who are suffering from Chronic Obstructive Pulmonary Disease (COPD) had a decreased&#xD;
      level of physical activity which is consequentially related to another acute exacerbation&#xD;
      event. In this study, we selected patients from those who were admitted for acute&#xD;
      exacerbation of COPD, evaluated physical activity by accelerometer (wearable multisensory&#xD;
      armband devices) to find out the correlation between physical activity in COPD acute&#xD;
      exacerbation patients.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">November 6, 2017</start_date>
  <completion_date type="Anticipated">December 2025</completion_date>
  <primary_completion_date type="Anticipated">November 19, 2025</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Crossover</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>13 Weeks</target_duration>
  <primary_outcome>
    <measure>Re admission rate after COPD acute exacerbation</measure>
    <time_frame>13 weeks</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">86</enrollment>
  <condition>COPD Exacerbation</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Based on COPD patients who visited Samsung medical center.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  COPD patient who have forced expiratory volume in one second/ forced vital capacity&#xD;
             (FEV1/FVC) &lt; 70% by spirometry and those who have not been admitted for acute&#xD;
             exacerbation in recent 3 months&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Those who does not consent or those who have drug addiction, psycho-socially or&#xD;
             medically not feasible to this study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Samsung medical center</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>February 13, 2018</study_first_submitted>
  <study_first_submitted_qc>February 13, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">February 19, 2018</study_first_posted>
  <last_update_submitted>October 8, 2021</last_update_submitted>
  <last_update_submitted_qc>October 8, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 18, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Samsung Medical Center</investigator_affiliation>
    <investigator_full_name>Hye Yun Park</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>Chronic obstructive pulmonary disease</keyword>
  <keyword>Chronic obstructive pulmonary disease acute exacerbation</keyword>
  <keyword>Physical activity</keyword>
  <keyword>Wearable arm device</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases, Obstructive</mesh_term>
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

